Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Improve Detection of ‘Winter Bugs’ with DiaSorin Molecular Technology

Published: Thursday, October 10, 2013
Last Updated: Thursday, October 10, 2013
Bookmark and Share
DiaSorin BUGS’n BEADS™ nucleic acid extraction kits for sensitive and accurate molecular identification of norovirus and Mycoplasma pneumonia.

DiaSorin LIAISON® Ixt / Arrow BUGS’n BEADS™ extraction kits provide high yield, high purity nucleic acid preparations for sensitive and accurate molecular identification of norovirus and Mycoplasma pneumonia.

As winter approaches, clinical laboratories are preparing for an increase in test requests for certain seasonal pathogens, such as norovirus and Mycoplasma pneumonia.

The DiaSorin BUGS’n BEADS™ nucleic acid extraction kits, for use with the automated DiaSorin LIAISON® Ixt / Arrow™ instruments, provide a highly purified nucleic acid preparation from patient samples for sensitive and accurate molecular confirmation of these microorganisms.

Outbreaks of norovirus, also known as winter vomiting disease, can spread quickly in certain semi-closed environments and frequently causes ward closures in hospitals during the winter months. Human noroviruses cannot be grown in cell culture and so diagnostic methods focus on the detection of viral RNA or antigen.

Mycoplasma pneumonia is a common cause of atypical pneumonia. Since other, less common etiological agents exist, which require a different course of treatment, identification of bacterial DNA in clinical samples has become increasingly important in establishing the cause of atypical pneumonia so that the optimal directed therapy can be provided for patients.

The sensitivity and accuracy of nucleic acid detection and amplification techniques can be reduced by interferences caused by the complexity of the sample matrix. The unique magnetic bead technology harnessed by the DiaSorin extraction kits overcomes this problem by concentrating the target microorganisms from a variety of sample matrices, including urine, sputum, culture and swabs, and then providing a highly purified nucleic acid extraction for downstream molecular analysis. No enzymatic pre-treatment or prior heat treatment is required.

The DiaSorin extraction kit solutions automate the purification and nucleic acid extraction process, reducing technician hands-on time and increasing sample throughput, making it ideal for the increasing workloads experienced during the winter months. The BUGS’n BEADS™ cartridges are simply loaded onto the LIAISON® Ixt / Arrow™ instrument for up to 12 patient samples and, in less than 45 minutes, a high yield, high purity nucleic acid preparation is then ready for use in a number of downstream applications.

DiaSorin BUGS’n BEADS™ can be used for the extraction of nucleic acid from a variety of pathogens, including Mycobacterium tuberculosis, enterovirus, MRSA, norovirus, Escherichia coli, Legionella, Mycoplasma pneumonia, Chlamydia pneumonia and Helicobacter pylori.

In addition to BUGS’n BEADS™, DiaSorin nucleic acid extraction kits are available for: the extraction of RNA or DNA; the extraction of DNA from stool and blood samples; and cell separation.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!